Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : COHANCEBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private

BSE1011.2088.1 (+9.54 %)

PREV CLOSE ( ) 923.10

OPEN PRICE ( ) 943.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 140049

TODAY'S LOW / HIGH ( )915.10 1038.00

52 WK LOW / HIGH ( )856.9 1359

NSE1012.9590.05 (+9.76 %)

PREV CLOSE( ) 922.90

OPEN PRICE ( ) 937.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1012.95 (12565)

VOLUME 4938667

TODAY'S LOW / HIGH( ) 914.25 1038.90

52 WK LOW / HIGH ( )856.3 1360

Chairman	Vivek Sharma
Managing Director	V Prasada Raju
Company Secretary	Kundan Kumar Jha
Non Executive Director	Shweta Jalan Pankaj Patwari Vinod Padikkal
Non Executive Independent Director	Vinod Rao Matangi Gowrishankar KG Ananthakrishnan UB Pravin Rao Jai Shankar Krishnan

Incorporation Year : 06-11 2018

Registered Office :

Address : 215 Atrium, C Wing, 8th Floor, 819-821,Andheri, Kurla Road, Chakala,Andheri (East), Chakala Midc Mumbai,
Maharashtra-400093 .

Phone : 022-61539999

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE